Z-0451-2021 Class II Terminated

Recalled by Ortho Clinical Diagnostics Inc — Raritan, NJ

FDA device recall Z-0451-2021 was initiated by Ortho Clinical Diagnostics Inc on Sep 30, 2020 and is designated Class II. Reason for recall: Elevated sample results signal/cutoff (s/c) values when using eight (8) lots of VITROS immunodiagnostic Products Anti-SARS-CoV-2 IgG Calibrator and decreased signal in one (1) lot of VITROS¿… The recall status is terminated (terminated Dec 7, 2023). Affected quantity: 691 units (OUS).

Recall details

Product Type
Devices
Report Date
Nov 25, 2020
Initiation Date
Sep 30, 2020
Termination Date
Dec 7, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
691 units (OUS)

Product description

VITROS¿ Immunodiagnostic Products Anti-SARS-CoV-2 IgG Control - Product Usage: For use in monitoring the performance of the VITROS Immunodiagnostic and Integrated Systems when used for the determination of IgG antibodies to SARS-CoV-2. Product Code (Unique Identifier): 6199921 (10758750033355)

Reason for recall

Elevated sample results signal/cutoff (s/c) values when using eight (8) lots of VITROS immunodiagnostic Products Anti-SARS-CoV-2 IgG Calibrator and decreased signal in one (1) lot of VITROS¿ Immunodiagnostic Products Anti-SARS-CoV-2 IgG Control

Distribution pattern

Worldwide distribution - US Nationwide distribution and the countries of Australia, Brazil, Chile, China, Colombia, India, Japan, Singapore 609917, United Kingdom, Italy.

Code information

Lot Number/ Exp. Date: 0110 25-NOV-20

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0451-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0451-2021. Report a data issue: hello@regdatalab.com.